استحداث أدوية جديدة (كالجانوفيا والجانومت والكالفص والكالفصمت والأونجلايوا والكومبلايزا ............

الأدوية الأخرى التابعة لهذا الصنف من الأدوية:

1. Sitagliptin (FDA approved 2006, marketed by Merck & Co. as Januvia)

2. Vildagliptin (EU approved 2007, marketed in the EU by Novartis as Galvus)

3. Saxagliptin (FDA approved in 2009, marketed as Onglyza)

4. Linagliptin (FDA approved in 2011, marketed as Tradjenta by Eli Lilly and Company and Boehringer Ingelheim)

5. Teneligliptin (approved in Japan in 2012)

6.